Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of GZR18 in Chinese adults with inadequately controlled type 2 diabetes mellitus on diet and exercise alone
CTR20244787Phase 3Active
- Sponsor
- Gannex Pharma Co., Ltd.
- Start
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing GZR18 injection with Placebo solvent injection (2 arms). Started Jan 2025; status: active.
02
Drugs
bofanglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20244787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244787.